Traversa Sergio (CIK 0001565832)

Latest company ownership

Shares held
1,272,500
Last filed at
Nov 6, 2025
Confidence Score
98.1
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
75,000
Last filed at
Mar 16, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 16, 2025 RELMADA THERAPEUTICS, INC. CEO Buy 82.5 +27,500 2.16% ✗ $113.3K
Nov 5, 2025 Nov 6, 2025 RELMADA THERAPEUTICS, INC. CEO Buy 97.5 +272,500 27.25% ✗ $599.5K
Aug 26, 2025 Aug 28, 2025 RELMADA THERAPEUTICS, INC. CEO Buy 95.0 +265,976 36.24% ✗ $178.1K
May 16, 2025 May 20, 2025 RELMADA THERAPEUTICS, INC. CEO Buy 95.0 +350,000 91.14% ✗ $174.7K
Sep 9, 2024 Sep 11, 2024 RELMADA THERAPEUTICS, INC. CEO Buy 97.5 +140,000 57.37% ✗ $395.1K
Jan 29, 2024 Jan 31, 2024 RELMADA THERAPEUTICS, INC. CEO Buy 97.5 +100,000 69.43% ✗ $386.7K
Dec 8, 2022 Dec 12, 2022 RELMADA THERAPEUTICS, INC. CEO Buy 95.0 +55,250 62.24% ✗ $115.8K
Jun 30, 2022 Jul 5, 2022 RELMADA THERAPEUTICS, INC. CEO Sell 20.0 -29,767 -5.94% ✗ $559.6K
Mar 9, 2021 Mar 11, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 20.0 -10,000 -3.52% ✗ $354.8K
Feb 24, 2021 Feb 26, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 20.0 -10,000 -10.12% ✗ $342.4K
Feb 11, 2021 Feb 16, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 22.5 -1,446 -1.60% ✗ $51.2K
Feb 8, 2021 Feb 10, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 20.0 -11,206 -11.21% ✗ $394.1K
Feb 2, 2021 Feb 4, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 22.5 -3,278 -1.81% ✗ $115K
Jan 27, 2021 Jan 29, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 20.0 -10,000 -11.70% ✗ $323.9K
Jan 22, 2021 Jan 26, 2021 RELMADA THERAPEUTICS, INC. CEO Sell 22.5 -4,070 -5.12% ✗ $144.2K
Aug 18, 2020 Aug 19, 2020 RELMADA THERAPEUTICS, INC. CEO Sell 22.5 -4,151 -5.21% ✗ $162K
Apr 14, 2016 Apr 18, 2016 Actinium Pharmaceuticals, Inc. Director Buy 90.0 +3,000 100.00% ✗ $6.1K
Dec 15, 2015 Dec 17, 2015 RELMADA THERAPEUTICS, INC. CEO Buy 90.0 +18,970 5.92% ✗ $57.8K
Dec 14, 2015 Dec 16, 2015 RELMADA THERAPEUTICS, INC. CEO Buy 47.5 +30 0.01% ✗ $89.1